These findings support the hypothesis that inhibition of immune function can be achieved through p110δ and p110γ inhibition, potentially leading to significant therapeutic effects in multiple inflammatory, autoimmune, and hematologic diseases. This evidence concerns the gene PIK3CD and hematologic disorder.